While GLP-1s and similar peptides famously suppress appetite, reduce blood sugar, and cause weight loss, a growing body of research suggests they might also do much more: curb inflammation all over your body, increase mitochondria in skeletal muscle to give you more energy and help you build strength, and reduce the risk of conditions ranging from Alzheimers to heart disease to alcohol use disorder
FDA Warning Letter Breakdown: Sterility Failures, Subpotent GLP-1 Drugs, and a Compounding Pharmacy Operating Without Control When compounded semaglutide and tirzepatide fail sterility and potency testing, and get distributed anyway, the implications extend far beyond one pharmacy
Semaglutide and Tirzepatide are available by prescription through Health Canada, though coverage varies by province and insurance plan
GLP-1 drugs are a branch of protein and peptide drugs, and their development represents an overall trend from short- to long-acting protein and peptide drugs
Most providers prefer injectable semaglutide for patients switching from injectable tirzepatide to maintain consistency in delivery method and bioavailability